KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Elevance Health (ELV) Income towards Parent Company (2016 - 2025)

Historic Income towards Parent Company for Elevance Health (ELV) over the last 16 years, with Q4 2025 value amounting to $546.0 million.

  • Elevance Health's Income towards Parent Company rose 3220.34% to $546.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $5.7 billion, marking a year-over-year decrease of 519.18%. This contributed to the annual value of $5.7 billion for FY2025, which is 519.18% down from last year.
  • Elevance Health's Income towards Parent Company amounted to $546.0 million in Q4 2025, which was up 3220.34% from $1.2 billion recorded in Q3 2025.
  • Elevance Health's 5-year Income towards Parent Company high stood at $2.3 billion for Q2 2024, and its period low was $413.0 million during Q4 2024.
  • Moreover, its 5-year median value for Income towards Parent Company was $1.6 billion (2022), whereas its average is $1.5 billion.
  • Per our database at Business Quant, Elevance Health's Income towards Parent Company surged by 57657.66% in 2021 and then tumbled by 5030.08% in 2024.
  • Over the past 5 years, Elevance Health's Income towards Parent Company (Quarter) stood at $1.2 billion in 2021, then fell by 25.61% to $877.0 million in 2022, then fell by 5.25% to $831.0 million in 2023, then tumbled by 50.3% to $413.0 million in 2024, then surged by 32.2% to $546.0 million in 2025.
  • Its Income towards Parent Company was $546.0 million in Q4 2025, compared to $1.2 billion in Q3 2025 and $1.7 billion in Q2 2025.